Article · 28 Feb 2025
Research articlePublished 3 May 2019
Formulation development and evaluation of oral disintegrating tablets of zolmitriptan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Orally disintegrating tablets (ODTs) are getting popularity over conventional tablets due totheir convenience in administration and suitability for patients having dysphagia (difficulty in swallowing). There is an increasing demand for more patient compliant dosage form and a novel method is the development orally disintegrating tablets which dissolve or disintegrates instantly on the patient tongue or buccal mucosa. It is suited for tablets undergoing high first pass metabolism and is used for improving bioavailability with reducing dosing frequency to minimize side effect and make it more cost effective. Zolmitriptan is a selective serotonin receptor agonist .Zolmitriptan , the absolute bioavailability is only approximately 40% due to extensive hepatic first pass metabolism (CYP1A2-mediated). Hence the main objective of the study was to formulate oral disintegrating tablets of Zolmitriptan to achieve a better dissolution rate and further improving the bioavailability of the drug. Orally disintegrating tablets prepared by direct compression and using Supertab11SD, Avicel PH 102, Crospovidone, Ac- Di-Sol, Sodium starch glycolate, Aspartame , Magnesium stearate were prepared and evaluated for the precompression parameters such as bulk density, compressibility, angle of repose etc. The prepared batches of tablets were evaluated for hardness, weight variation, friability, disintegration time and in-vitro dissolution profile and found satisfactory. Among the three groups, F9 Formulation as the best formulation and showed maximum dissolution rate with drug release.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Der Pharmacia Lettre.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “N. Hazee Peera”
- BylineArticles whose byline prints “D. Lohithasu”
- BylineArticles whose byline prints “S. K. Sahoo”
- BylineArticles whose byline prints “M. Santhosh Naidu”
- BylineArticles whose byline prints “K. Mani Kumar”
- BylineArticles whose byline prints “V. Anil Kumar”